Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rota-biome: Microbiome and Vaccine Response
NCT02538211Completed
- Sponsor
- University of Amsterdam
- Start
- Sep 2015
- Primary completion
- Jan 2017
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
Randomised, open-label trial of rotavirus vaccine, live, oral in rotavirus infection (3 arms), sponsored by University of Amsterdam. Primary endpoint: Serum anti-rotavirus Immunoglobulin A response. Started Sep 2015; status: completed.
02
Drugs
rotavirus vaccine, live, oral
03
Conditions
rotavirus infection
Beyond the preview
Go deeper on NCT02538211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02538211.